LEMAITRE VASCULAR INC (LMAT) Fundamental Analysis & Valuation
NASDAQ:LMAT • US5255582018
Current stock price
111.82 USD
+2.07 (+1.89%)
Last:
This LMAT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. LMAT Profitability Analysis
1.1 Basic Checks
- LMAT had positive earnings in the past year.
- LMAT had a positive operating cash flow in the past year.
- Each year in the past 5 years LMAT has been profitable.
- In the past 5 years LMAT always reported a positive cash flow from operatings.
1.2 Ratios
- LMAT has a Return On Assets of 9.38%. This is amongst the best in the industry. LMAT outperforms 89.30% of its industry peers.
- LMAT's Return On Equity of 14.67% is amongst the best of the industry. LMAT outperforms 89.30% of its industry peers.
- With an excellent Return On Invested Capital value of 9.04%, LMAT belongs to the best of the industry, outperforming 87.70% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for LMAT is in line with the industry average of 9.14%.
- The last Return On Invested Capital (9.04%) for LMAT is above the 3 year average (8.61%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.38% | ||
| ROE | 14.67% | ||
| ROIC | 9.04% |
ROA(3y)8.68%
ROA(5y)8.37%
ROE(3y)12.61%
ROE(5y)11.22%
ROIC(3y)8.61%
ROIC(5y)8.85%
1.3 Margins
- LMAT has a better Profit Margin (23.13%) than 94.65% of its industry peers.
- LMAT's Profit Margin has improved in the last couple of years.
- The Operating Margin of LMAT (27.21%) is better than 96.26% of its industry peers.
- LMAT's Operating Margin has improved in the last couple of years.
- The Gross Margin of LMAT (71.53%) is better than 80.75% of its industry peers.
- LMAT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.21% | ||
| PM (TTM) | 23.13% | ||
| GM | 71.53% |
OM growth 3Y13.74%
OM growth 5Y4.46%
PM growth 3Y22%
PM growth 5Y7.14%
GM growth 3Y3.31%
GM growth 5Y1.81%
2. LMAT Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), LMAT is creating some value.
- The number of shares outstanding for LMAT has been increased compared to 1 year ago.
- LMAT has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for LMAT has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 8.78 indicates that LMAT is not in any danger for bankruptcy at the moment.
- LMAT has a Altman-Z score of 8.78. This is amongst the best in the industry. LMAT outperforms 85.03% of its industry peers.
- The Debt to FCF ratio of LMAT is 2.26, which is a good value as it means it would take LMAT, 2.26 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 2.26, LMAT belongs to the best of the industry, outperforming 84.49% of the companies in the same industry.
- A Debt/Equity ratio of 0.43 indicates that LMAT is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.43, LMAT is in line with its industry, outperforming 43.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 2.26 | ||
| Altman-Z | 8.78 |
ROIC/WACC1.04
WACC8.73%
2.3 Liquidity
- A Current Ratio of 12.89 indicates that LMAT has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 12.89, LMAT belongs to the best of the industry, outperforming 98.40% of the companies in the same industry.
- LMAT has a Quick Ratio of 10.95. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
- LMAT has a Quick ratio of 10.95. This is amongst the best in the industry. LMAT outperforms 97.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 12.89 | ||
| Quick Ratio | 10.95 |
3. LMAT Growth Analysis
3.1 Past
- LMAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.68%, which is quite impressive.
- The Earnings Per Share has been growing by 17.12% on average over the past years. This is quite good.
- LMAT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.53%.
- The Revenue has been growing by 14.04% on average over the past years. This is quite good.
EPS 1Y (TTM)22.68%
EPS 3Y36.78%
EPS 5Y17.12%
EPS Q2Q%38.78%
Revenue 1Y (TTM)13.53%
Revenue growth 3Y15.57%
Revenue growth 5Y14.04%
Sales Q2Q%15.68%
3.2 Future
- The Earnings Per Share is expected to grow by 11.37% on average over the next years. This is quite good.
- The Revenue is expected to grow by 9.67% on average over the next years. This is quite good.
EPS Next Y24.41%
EPS Next 2Y16.72%
EPS Next 3Y12.89%
EPS Next 5Y11.37%
Revenue Next Year12.71%
Revenue Next 2Y10.78%
Revenue Next 3Y10.08%
Revenue Next 5Y9.67%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. LMAT Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 46.98 indicates a quite expensive valuation of LMAT.
- Based on the Price/Earnings ratio, LMAT is valued a bit cheaper than the industry average as 66.31% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of LMAT to the average of the S&P500 Index (26.77), we can say LMAT is valued expensively.
- LMAT is valuated quite expensively with a Price/Forward Earnings ratio of 37.76.
- Based on the Price/Forward Earnings ratio, LMAT is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
- When comparing the Price/Forward Earnings ratio of LMAT to the average of the S&P500 Index (21.75), we can say LMAT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.98 | ||
| Fwd PE | 37.76 |
4.2 Price Multiples
- 71.66% of the companies in the same industry are more expensive than LMAT, based on the Enterprise Value to EBITDA ratio.
- 77.01% of the companies in the same industry are more expensive than LMAT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.21 | ||
| EV/EBITDA | 25.26 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of LMAT may justify a higher PE ratio.
- LMAT's earnings are expected to grow with 12.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.92
PEG (5Y)2.74
EPS Next 2Y16.72%
EPS Next 3Y12.89%
5. LMAT Dividend Analysis
5.1 Amount
- LMAT has a yearly dividend return of 0.89%, which is pretty low.
- Compared to an average industry Dividend Yield of 0.25, LMAT pays a better dividend. On top of this LMAT pays more dividend than 91.44% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.82, LMAT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.89% |
5.2 History
- On average, the dividend of LMAT grows each year by 16.13%, which is quite nice.
- LMAT has paid a dividend for at least 10 years, which is a reliable track record.
- LMAT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)16.13%
Div Incr Years14
Div Non Decr Years14
5.3 Sustainability
- 31.37% of the earnings are spent on dividend by LMAT. This is a low number and sustainable payout ratio.
- LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP31.37%
EPS Next 2Y16.72%
EPS Next 3Y12.89%
LMAT Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:LMAT (5/1/2026, 2:31:09 PM)
111.82
+2.07 (+1.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength11.18
Industry Growth60.87
Earnings (Last)02-25 2026-02-25/amc
Earnings (Next)05-05 2026-05-05
Inst Owners95.94%
Inst Owner Change0.72%
Ins Owners7.04%
Ins Owner Change-9.8%
Market Cap2.55B
Revenue(TTM)249.60M
Net Income(TTM)57.73M
Analysts80
Price Target113.07 (1.12%)
Short Float %6.45%
Short Ratio5.67
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.89% |
Yearly Dividend0.8
Dividend Growth(5Y)16.13%
DP31.37%
Div Incr Years14
Div Non Decr Years14
Ex-Date03-12 2026-03-12 (0.25)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.9%
Min EPS beat(2)0.42%
Max EPS beat(2)7.38%
EPS beat(4)3
Avg EPS beat(4)1.52%
Min EPS beat(4)-5.52%
Max EPS beat(4)7.38%
EPS beat(8)6
Avg EPS beat(8)4.19%
EPS beat(12)10
Avg EPS beat(12)5.13%
EPS beat(16)10
Avg EPS beat(16)-0.04%
Revenue beat(2)1
Avg Revenue beat(2)-1.58%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)0.58%
Revenue beat(4)3
Avg Revenue beat(4)-0.13%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)1.83%
Revenue beat(8)5
Avg Revenue beat(8)-0.14%
Revenue beat(12)7
Avg Revenue beat(12)0.21%
Revenue beat(16)8
Avg Revenue beat(16)-0.25%
PT rev (1m)6.94%
PT rev (3m)6.94%
EPS NQ rev (1m)0.15%
EPS NQ rev (3m)7.26%
EPS NY rev (1m)2.94%
EPS NY rev (3m)12.21%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)1.1%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)3.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.98 | ||
| Fwd PE | 37.76 | ||
| P/S | 10.21 | ||
| P/FCF | 34.21 | ||
| P/OCF | 31.35 | ||
| P/B | 6.47 | ||
| P/tB | 8.65 | ||
| EV/EBITDA | 25.26 |
EPS(TTM)2.38
EY2.13%
EPS(NY)2.96
Fwd EY2.65%
FCF(TTM)3.27
FCFY2.92%
OCF(TTM)3.57
OCFY3.19%
SpS10.96
BVpS17.27
TBVpS12.93
PEG (NY)1.92
PEG (5Y)2.74
Graham Number30.4147 (-72.8%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.38% | ||
| ROE | 14.67% | ||
| ROCE | 11.72% | ||
| ROIC | 9.04% | ||
| ROICexc | 23.78% | ||
| ROICexgc | 43.2% | ||
| OM | 27.21% | ||
| PM (TTM) | 23.13% | ||
| GM | 71.53% | ||
| FCFM | 29.83% |
ROA(3y)8.68%
ROA(5y)8.37%
ROE(3y)12.61%
ROE(5y)11.22%
ROIC(3y)8.61%
ROIC(5y)8.85%
ROICexc(3y)18.5%
ROICexc(5y)16.17%
ROICexgc(3y)34.8%
ROICexgc(5y)32.81%
ROCE(3y)11.16%
ROCE(5y)11.48%
ROICexgc growth 3Y19.07%
ROICexgc growth 5Y8.49%
ROICexc growth 3Y27.82%
ROICexc growth 5Y16.94%
OM growth 3Y13.74%
OM growth 5Y4.46%
PM growth 3Y22%
PM growth 5Y7.14%
GM growth 3Y3.31%
GM growth 5Y1.81%
F-Score7
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 2.26 | ||
| Debt/EBITDA | 2.15 | ||
| Cap/Depr | 65.11% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 103.73% | ||
| Profit Quality | 128.99% | ||
| Current Ratio | 12.89 | ||
| Quick Ratio | 10.95 | ||
| Altman-Z | 8.78 |
F-Score7
WACC8.73%
ROIC/WACC1.04
Cap/Depr(3y)71.15%
Cap/Depr(5y)58.36%
Cap/Sales(3y)3.21%
Cap/Sales(5y)2.96%
Profit Quality(3y)103.77%
Profit Quality(5y)106.24%
High Growth Momentum
Growth
EPS 1Y (TTM)22.68%
EPS 3Y36.78%
EPS 5Y17.12%
EPS Q2Q%38.78%
EPS Next Y24.41%
EPS Next 2Y16.72%
EPS Next 3Y12.89%
EPS Next 5Y11.37%
Revenue 1Y (TTM)13.53%
Revenue growth 3Y15.57%
Revenue growth 5Y14.04%
Sales Q2Q%15.68%
Revenue Next Year12.71%
Revenue Next 2Y10.78%
Revenue Next 3Y10.08%
Revenue Next 5Y9.67%
EBIT growth 1Y29.96%
EBIT growth 3Y31.45%
EBIT growth 5Y19.13%
EBIT Next Year39.22%
EBIT Next 3Y19.89%
EBIT Next 5Y16.94%
FCF growth 1Y100.39%
FCF growth 3Y49.81%
FCF growth 5Y18.54%
OCF growth 1Y84.14%
OCF growth 3Y47.38%
OCF growth 5Y18.48%
LEMAITRE VASCULAR INC / LMAT Fundamental Analysis FAQ
What is the ChartMill fundamental rating of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a fundamental rating of 7 / 10 to LMAT.
What is the valuation status of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a valuation rating of 4 / 10 to LEMAITRE VASCULAR INC (LMAT). This can be considered as Fairly Valued.
Can you provide the profitability details for LEMAITRE VASCULAR INC?
LEMAITRE VASCULAR INC (LMAT) has a profitability rating of 9 / 10.
What is the expected EPS growth for LEMAITRE VASCULAR INC (LMAT) stock?
The Earnings per Share (EPS) of LEMAITRE VASCULAR INC (LMAT) is expected to grow by 24.41% in the next year.
Can you provide the dividend sustainability for LMAT stock?
The dividend rating of LEMAITRE VASCULAR INC (LMAT) is 6 / 10 and the dividend payout ratio is 31.37%.